JNJ-40346527 Completed Phase 1 Trials for Health Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01054014A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers